Variant report
Variant | esv3425142 |
---|---|
Chromosome Location | chr1:112811829-112815427 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199805862 | chr1:112811905-112811906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535487588 | chr1:112811929-112811930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373426353 | chr1:112811944-112811945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12094942 | chr1:112812019-112812020 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs565729553 | chr1:112812106-112812107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549251030 | chr1:112812148-112812149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183448669 | chr1:112812177-112812178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559648843 | chr1:112812187-112812188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577834406 | chr1:112812272-112812273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4531294 | chr1:112812289-112812290 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs145312366 | chr1:112812320-112812321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188618279 | chr1:112812359-112812360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573729740 | chr1:112812361-112812362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542353830 | chr1:112812416-112812417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9429673 | chr1:112812417-112812418 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs192720943 | chr1:112812435-112812436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554377113 | chr1:112812442-112812443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545345719 | chr1:112812500-112812501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565142877 | chr1:112812503-112812504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147244707 | chr1:112812508-112812509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139714825 | chr1:112812510-112812511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533489336 | chr1:112812522-112812523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149775090 | chr1:112812534-112812535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528675000 | chr1:112812575-112812576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549191977 | chr1:112812609-112812610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565762488 | chr1:112812617-112812618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35470067 | chr1:112812640-112812641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184344904 | chr1:112812647-112812648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145738400 | chr1:112812688-112812689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72978004 | chr1:112812710-112812711 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs537250228 | chr1:112812711-112812712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148961208 | chr1:112812713-112812714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188437335 | chr1:112812737-112812738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144368762 | chr1:112812757-112812758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs3128363 | chr1:112812855-112812856 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs191628110 | chr1:112812860-112812861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146614477 | chr1:112812873-112812874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141422789 | chr1:112812923-112812924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74692928 | chr1:112812943-112812944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114189363 | chr1:112812944-112812945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549120023 | chr1:112812995-112812996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561172736 | chr1:112813080-112813081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555159964 | chr1:112813083-112813084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529826246 | chr1:112813085-112813086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549476668 | chr1:112813108-112813109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375599313 | chr1:112813132-112813133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528474071 | chr1:112813150-112813151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12097458 | chr1:112813152-112813153 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs528207270 | chr1:112813169-112813170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184445305 | chr1:112813199-112813200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Asthma | 20841430 | CNVD |
Aetanephric adenomas | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 16573809 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Breast cancer | 17899364 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Melanoma | 19671679 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:112788800-112812200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr1:112808200-112815200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
3 | chr1:112811000-112812400 | Weak transcription | Lung | lung |
4 | chr1:112811400-112812400 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
5 | chr1:112811400-112815200 | Weak transcription | Right Atrium | heart |
6 | chr1:112812400-112812600 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr1:112812600-112812800 | Enhancers | Lung | lung |
8 | chr1:112813600-112815200 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
9 | chr1:112814200-112814400 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr1:112814200-112815800 | Enhancers | GM12878-XiMat | blood |
11 | chr1:112814400-112814600 | Enhancers | HSMMtube | muscle |
12 | chr1:112814400-112815000 | Weak transcription | Brain Hippocampus Middle | brain |
13 | chr1:112815200-112815400 | Enhancers | Brain Hippocampus Middle | brain |
14 | chr1:112815200-112815400 | Enhancers | Brain Inferior Temporal Lobe | brain |
15 | chr1:112815200-112815400 | Enhancers | HSMMtube | muscle |
16 | chr1:112815200-112815600 | Enhancers | Right Atrium | heart |
17 | chr1:112815200-112815800 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |